Tags

Type your tag names separated by a space and hit enter

Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease.
Surg Obes Relat Dis. 2009 Mar-Apr; 5(2):139-43.SO

Abstract

BACKGROUND

Gastroesophageal reflux disease (GERD) is commonly associated with morbid obesity. Laparoscopic fundoplication is a standard surgical treatment for GERD, and laparoscopic gastric bypass has been shown to effectively resolve GERD symptoms in the morbidly obese. We sought to compare the in-hospital outcomes of morbidly obese patients who underwent laparoscopic fundoplication for the treatment of GERD versus laparoscopic gastric bypass for the treatment of morbid obesity and related conditions, including GERD, at U.S. academic medical centers.

METHODS

Using the "International Classification of Diseases, 9th Revision" procedural and diagnoses codes for morbidly obese patients with GERD, we obtained data from the University HealthSystem Consortium database for all patients who underwent laparoscopic fundoplication or laparoscopic gastric bypass from October 2004 to December 2007 (n=27,264). The outcome measures included the patient demographics, length of stay, in-hospital overall complications, mortality, risk-adjusted mortality ratio (observed to expected mortality), and hospital costs.

RESULTS

Compared with the patients who underwent laparoscopic gastric bypass, those who underwent laparoscopic fundoplication had a lower severity of illness score (P<.05). The overall in-hospital complications were significantly lower in the laparoscopic gastric bypass group (P<.05). The mean length of stay, observed mortality, risk-adjusted mortality, and hospital costs were comparable between the 2 treatment groups.

CONCLUSION

Laparoscopic gastric bypass is as safe as laparoscopic fundoplication for the treatment of GERD in the morbidly obese. Hence, morbidly obese patients with GERD should be referred for bariatric surgery evaluation and offered laparoscopic gastric bypass as a surgical option.

Authors+Show Affiliations

Surgical Service, Veterans Affairs North Texas Health Care System, Dallas, Texas 75216, USA. esteban.varela@utsouthwestern.eduNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Multicenter Study

Language

eng

PubMed ID

18996768

Citation

Varela, J Esteban, et al. "Laparoscopic Fundoplication Compared With Laparoscopic Gastric Bypass in Morbidly Obese Patients With Gastroesophageal Reflux Disease." Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, vol. 5, no. 2, 2009, pp. 139-43.
Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis. 2009;5(2):139-43.
Varela, J. E., Hinojosa, M. W., & Nguyen, N. T. (2009). Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, 5(2), 139-43. https://doi.org/10.1016/j.soard.2008.08.021
Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic Fundoplication Compared With Laparoscopic Gastric Bypass in Morbidly Obese Patients With Gastroesophageal Reflux Disease. Surg Obes Relat Dis. 2009 Mar-Apr;5(2):139-43. PubMed PMID: 18996768.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. AU - Varela,J Esteban, AU - Hinojosa,Marcelo W, AU - Nguyen,Ninh T, Y1 - 2008/09/04/ PY - 2008/05/23/received PY - 2008/08/21/revised PY - 2008/08/26/accepted PY - 2008/11/11/pubmed PY - 2009/6/10/medline PY - 2008/11/11/entrez SP - 139 EP - 43 JF - Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery JO - Surg Obes Relat Dis VL - 5 IS - 2 N2 - BACKGROUND: Gastroesophageal reflux disease (GERD) is commonly associated with morbid obesity. Laparoscopic fundoplication is a standard surgical treatment for GERD, and laparoscopic gastric bypass has been shown to effectively resolve GERD symptoms in the morbidly obese. We sought to compare the in-hospital outcomes of morbidly obese patients who underwent laparoscopic fundoplication for the treatment of GERD versus laparoscopic gastric bypass for the treatment of morbid obesity and related conditions, including GERD, at U.S. academic medical centers. METHODS: Using the "International Classification of Diseases, 9th Revision" procedural and diagnoses codes for morbidly obese patients with GERD, we obtained data from the University HealthSystem Consortium database for all patients who underwent laparoscopic fundoplication or laparoscopic gastric bypass from October 2004 to December 2007 (n=27,264). The outcome measures included the patient demographics, length of stay, in-hospital overall complications, mortality, risk-adjusted mortality ratio (observed to expected mortality), and hospital costs. RESULTS: Compared with the patients who underwent laparoscopic gastric bypass, those who underwent laparoscopic fundoplication had a lower severity of illness score (P<.05). The overall in-hospital complications were significantly lower in the laparoscopic gastric bypass group (P<.05). The mean length of stay, observed mortality, risk-adjusted mortality, and hospital costs were comparable between the 2 treatment groups. CONCLUSION: Laparoscopic gastric bypass is as safe as laparoscopic fundoplication for the treatment of GERD in the morbidly obese. Hence, morbidly obese patients with GERD should be referred for bariatric surgery evaluation and offered laparoscopic gastric bypass as a surgical option. SN - 1550-7289 UR - https://www.unboundmedicine.com/medline/citation/18996768/Laparoscopic_fundoplication_compared_with_laparoscopic_gastric_bypass_in_morbidly_obese_patients_with_gastroesophageal_reflux_disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1550-7289(08)00678-3 DB - PRIME DP - Unbound Medicine ER -